SARS Pneumonia
22
0
0
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.6%
3 terminated out of 22 trials
81.3%
-5.3% vs benchmark
14%
3 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (22)
Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)
Follow-up of Covid-19 Long Term Sequelae
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Characteristics of Patients With COVID-19 in Meta State, Colombia
Cardiovascular Implications of COVID-19
Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand
Glycine Supplement for Severe COVID-19
Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
A Study of ResCure™ to Treat COVID-19 Infection
A Study of Combination Therapies to Treat COVID-19 Infection
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth
Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial
Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19